Skip to main content
DNA Labs India

MTRR Gene Spina bifida folate sensitive NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

MTRR Gene Spina bifida folate sensitive NGS Genetic Test

Short Name: MTRR Spina Bifida NGS

Also known as: MTRR Gene Mutation Test, Folate Metabolism Genetic Test, Spina Bifida Risk Assessment

MTRR Gene Spina bifida folate sensitive NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks from sample receipt at the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify mutations in the MTRR gene that may increase susceptibility to folate-sensitive spina bifida. It aids in risk assessment for individuals with a family history of neural tube defects, couples planning pregnancy, and patients with unexplained folate metabolism issues. The results can guide folate supplementation, prenatal screening, and reproductive counseling.

Test Code
5938
CPT Code
81405
ICD Code
Q05.9
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks from sample receipt at the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation required. Inform your healthcare provider about any medications or supplements, especially folate, as they may influence interpretation.

Method: Venipuncture or Fingerstick

Step 2

Laboratory Analysis

A blood sample will be drawn from a vein in your arm. If using FTA card, a simple fingerstick is performed.

Step 3

Report Delivery

No restrictions. You can resume normal activities immediately.

Timeline: 3 to 4 weeks from sample receipt at the laboratory.

Patient Instructions

1
Before the Test:No special preparation required. However, it is recommended to have a genetic counseling session before the test to understand the implications.
2
During the Test:A simple blood draw or fingerstick will be performed. The procedure is quick and minimally invasive.
3
After the Test:You can resume normal activities. Results will be available in 3-4 weeks and will be communicated via your preferred method.

About This Test

Who Should Get This Test

The purpose of this test is to identify mutations in the MTRR gene that may increase susceptibility to folate-sensitive spina bifida. It aids in risk assessment for individuals with a family history of neural tube defects, couples planning pregnancy, and patients with unexplained folate metabolism issues. The results can guide folate supplementation, prenatal screening, and reproductive counseling.

How to Prepare

  • For blood sample: Use EDTA vacutainer, fill to indicated mark, mix gently.
  • For FTA card: Apply one drop of blood onto the designated circle, allow to air dry.
  • Label the sample with patient name, date, and time of collection.
  • Transport at ambient temperature (15-30°C) within 24 hours.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Early identification of MTRR mutations can guide folate supplementation and prenatal management, potentially reducing the risk of neural tube defects."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or 1 drop on FTA card
ContainerEDTA vacutainer or FTA card
Collection MethodVenipuncture or Fingerstick

Sample Stability

Whole blood (EDTA)72 hours
FTA card6 months
Extracted DNA1 year
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Insufficient sample volume
  • Improperly labeled sample
  • Sample received after prolonged storage without proper temperature

Understanding Your Results

The test report will indicate whether any pathogenic or likely pathogenic variants were identified in the MTRR gene. If a variant is found, the report will include its clinical significance and recommendations for management.
📊

No pathogenic variants detected

No increased genetic risk for folate-sensitive spina bifida identified through MTRR gene analysis.

Recommendation: Continue standard prenatal care and folate supplementation as recommended.

📊

Pathogenic or Likely Pathogenic variant detected

Presence of a mutation that may impair folate metabolism, increasing risk of neural tube defects.

Recommendation: Consult a genetic counselor and obstetrician for personalized folate supplementation (e.g., higher dose) and prenatal monitoring.

📊

Variant of Uncertain Significance (VUS)

A genetic variant was found, but its impact on health is currently unknown.

Recommendation: Further family studies or functional assays may be needed. Discuss with a genetic counselor.

⚠️ When to Consult a Doctor:

Consult a healthcare provider if you have a family history of spina bifida, have had a previous child with a neural tube defect, or are planning pregnancy and want to assess your genetic risk.

Limitations

  • This test only analyzes the MTRR gene; other genes may also contribute to spina bifida risk
  • Variants of uncertain significance (VUS) may be reported and require further investigation
  • Does not detect large deletions/duplications or deep intronic variants
  • Not a diagnostic test for spina bifida; it assesses genetic risk only

Risks & Considerations

  • Minimal risk of bruising or infection at the blood draw site
  • Psychological impact of learning genetic risk
  • Potential for uncertain results (VUS)

Interfering Factors

  • Recent blood transfusion (within 2 weeks) may dilute DNA
  • Bone marrow transplant can affect results
  • Contaminated or degraded DNA samples
  • Incorrect sample storage or transport

Compare With Similar Tests

TestMTRR Gene Spina bifida folate sensitive NGS Genetic TestMTHFR Gene Mutation TestFolate Metabolism Panel (MTHFR + MTRR)Whole Exome Sequencing
ComparisonMTRR Gene Spina bifida folate sensitive NGS Genetic Test

Frequently Asked Questions

What is the MTRR gene and its role in spina bifida?
The MTRR gene provides instructions for making methionine synthase reductase, an enzyme that helps recycle folate in the body. Proper folate metabolism is crucial for neural tube closure during fetal development. Mutations in MTRR can impair this process, increasing the risk of spina bifida.
Who should consider this genetic test?
Individuals with a family history of spina bifida, those who have had a previous child with a neural tube defect, couples planning pregnancy, and people with unexplained folate metabolism issues may benefit from this test.
What is the cost of the MTRR gene spina bifida NGS test in India?
The cost is INR 20,000 at DNA Labs India. This includes genetic counseling, NGS sequencing, and a comprehensive clinical report with raw data files.
What sample is required for the test?
A blood sample (2-3 ml in EDTA tube) or a single drop of blood on an FTA card is sufficient. Extracted DNA can also be submitted.
How long does it take to get results?
The turnaround time is 3 to 4 weeks from the date the sample is received at the laboratory.
Does the test require fasting?
No, fasting is not required for this genetic test. You can eat and drink normally before sample collection.
Will I receive raw data files?
Yes, DNA Labs India is transparent and provides raw data files (FASTQ, VCF) along with the clinical report for your records and further analysis.
What does a positive result mean?
A positive result indicates the presence of a pathogenic or likely pathogenic variant in the MTRR gene, which may increase the risk of folate-sensitive spina bifida. It is not a diagnosis of spina bifida but a risk factor.
Can this test be done during pregnancy?
Yes, the test can be performed during pregnancy. However, it is best to consult with your obstetrician or genetic counselor to understand the implications for prenatal care.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for online bookings across major cities in India.
What is the difference between MTRR and MTHFR gene testing?
Both genes are involved in folate metabolism, but they encode different enzymes. MTHFR converts folate to its active form, while MTRR helps recycle it. Testing both provides a more complete picture of folate metabolism.
Are there any risks associated with the test?
The test is safe with minimal risks, such as slight bruising at the blood draw site. The main consideration is the psychological impact of learning your genetic risk, which is why genetic counseling is included.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.